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ABSTRAK 
Pengenalan: 
Kajian menunjukkan prevalen penyakit asma dan penyakit alahan semakin 
meningkat. Samada ia menunjukkan peningkatan yang sebenar adalah 
bergantung kepada bagaimana ibubapa menjawab soalan kajian tersebut. 
Penyiasatan juga menunjukkan terdapat masalah didalam komplian terhadap ubat 
asma terutamanya ubat inhalasi. 
Objektif: 
1. Menyiasat interpretasi ibubapa terhadap gejala-gejala biasa penyakit asma dan 
alahan. 
2. Untuk mengetahui anggapan ibubapa terhadap penggunaan ubat inhalasi 
didalam perawatan penyakit asma. 
Metodologi: 
Temuramah dijalankan dari bulan Mac 2001 sehingga bulan September 2002 di 
HUSM dan HKB. lbubapa kepada pesakit asma yang datang untuk rawatan 
Janjutan diklinik asma HUSM dan HKB dan juga ibubapa kepada pesakit asma 
yang dimasukkan kedalam wad pediatrik HUSM kerana serangan asma 
dimasukkan ke dalam kajian. lbubapa kepada pesakit yang tidak mengalami asma 
dijadikan kumpulan kontrol. lbubapa ditemuramah menggunakan soalan yang 
telah disediakan mengandungi data berkaitan faktor demografi, interpretasi 
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kepada gejala biasa penyakit asma dan penyakit alahan, dan pandangan ibu bapa 
terhadap ubat asma. 
Keputusan: 
Seratus peratus ibubapa kepada pesakit asma mengatakan anak mereka pernah 
mengalami Ieiah manakala hanya 7.6°/o ibubapa kepada kanak-kanak bukan asma 
mengatakan anak mereka pernah Ieiah. (P<0.001 ). Sebahagian besar ibubapa 
menginterpretasikan Ieiah sebagai susah bernafas. lbubapa mengalami masalah 
didalam menginterpretasikan nafas berbunyi dan tiada satu perkataan pun yang 
sesuai untuk menerangkannya. Kebanyakan ibubapa (59.3°/o) hanya meniru bunyi 
yang mereka den gar dan tidak dapat menyatakannya menggunakan perkataan 
yangtepat. 
88.9o/o ibubapa kepada pesakit asma yang juga menghidapi "allergic rhinitis" 
menyatakan bahawa anak mereka mengalami resdung dan hanya 14.7°/o ibubapa 
kepada kanak-kanak asma yang bukan pengidap "allergic rhinitis" mengatakan 
anak mereka mengalami "resdung" (P<0.001 ). Untuk "eczema", tiada perkataan 
khusus untuk menyatakannya. 
Kebanyakan ibubapa menyatakan mereka menyukai ubat inhalasi (68.5°/o ), tetapi 
mereka tetap bimbang penggunaan ubat inhalasi untuk jangkamasa yang panjang 
terutama terhadap kesan sampingan ubat dan takut terlampau bergantung kepada 
ubat. 
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Kesimpulan: 
Perkataan Ielah telah digunakan oleh semua ibubapa kepada pesakit asma dan 
segolongan besar menginterpretasikan Ielah sebagai susah bernafas. Tiada 
perkataan yang khusus untuk menginterpretasikan nafas berbunyi. Masyarakat 
kita juga tidak menyatakan bahawa nafas berbunyi adalah bunyi seperti siulan 
sepertimana yang biasa digunakan didalam soalan kajian. Perkataan resdung 
digunakan oleh 88.9°/o ibubapa kepada pesakit asma yang juga menghidapi 
"allergic rhinitis". Perkataan resdung juga boleh digunakan untuk menyatakan 
gejala-gejala yang di alami disebabkan penyakit-penyakit hi dung yang lain seperti 
selsema, jangkitan kuman dan lain-lain. Penggunaan ubat inhalasi adalah 
berpatutan didalam masyarakat kita. 
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ABSTRACT 
Introduction: 
Survey evidence indicates an increased prevalence of asthma and atopic diseases 
in childhood. Whether it represents the true increment depends on the ways in 
which parents respond to survey questions. Studies also showed that there are 
problems in compliance towards asthma medications especially inhalers. 
Objectives: 
1. To investigate parents' interpretation of the common symptoms of asthma and 
atopic diseases. 
2. To describe parents' perception towards the use of inhaled medication for 
asthma therapy. 
Methodology: 
An interview was conducted from March 2001 to September 2002 in HKB and 
HUSM. Parents of asthmatic children who attended asthma clinic at HUSM and 
HKB and whose children were admitted for asthma to the paediatric general ward 
HUSM were included in the study. Parents of non-asthmatic children who attended 
paediatric clinic at HUSM and whose children were admitted to the paediatric 
general ward HUSM were recruited as controls. Parents were interviewed using a 
standard questionnaire containing demographic data, interpretation on common 
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respiratory symptoms and atopic disease and their perception towards asthma 
medications. 
Results: 
One hundred percent of parents of asthmatic children mentioned that their children 
ever had "Ielah" compared to 7 .6°/o parents of non-asthmatic children (P<0.001 ). 
The majority of parents described "Ielah" as difficulty in breathing (64.3o/o for 
asthmatic group and 83.5°/o for non-asthmatic group). The parents had difficulty in 
the interpretation of noisy breathing, most of the parents (59.3°/o) only imitate the 
sounds. 88.9o/o of parents of asthmatic children who have allergic rhinitis said their 
children had uresdung" whereas only 14. 7o/o of parents of asthmatic children who 
did not have allergic rhinitis said their children had "resdung" (P<0.001 ). For 
eczema, there were no any specific words which can represent eczema. 
A majority of parents preferred the usage of inhalers (68.5°/o) but they were 
concerned about the side effects of long-term usage and dependency towards the 
drugs. 
Xl 
Conclusion: 
Word "Ielah" was used by all parents of asthmatic children and a majority describe 
"Ielah" as difficulty in breathing. There were no specific words to described noisy 
breathing. Our population did not describe the noisy breathing as whistling as had 
been used in the survey questionnaire. Word "resdung" was used by 88.9o/o of 
parents of asthmatic children who have allergic rhinitis. "Resdung" can also be 
used to describe nasal symptoms due to other nasal problems such as flu, 
infection and others. This may explained the low positive predictive value (62.7o/o) 
of "resdung". The use of inhalers was appropriate for our population. 
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1. INTRODUCTION 
1.1 Background of the study 
Epidemiological studies conducted worldwide suggest an increasing prevalence of 
childhood wheezing illnesses, under diagnosis and under treatment of asthma. 
Reported wheeze is considered central to diagnosing asthma and measuring 
asthma prevalence. However, establishing the real prevalence of wheeze is 
problematic. (Cane et al, 2000) 
Most estimates of the prevalence of asthma are based on the data from 
questionnaires about asthmatic symptoms or from the diagnosis performed by a 
physician. The standardized questionnaire is used to study the prevalence of 
asthma. 
The International Study of Asthma and Allergies in Childhood (ISAAC) has 
established internationally an acceptable paediatric questionnaire with 
standardised methodology to compare the prevalence and severity of asthma and 
atopic diseases in children, both within and between countries (Kaur et al. 1998). 
Using an identical questionnaire, comparisons of prevalent figures among different 
countries are more valid. 
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ISAAC Phase One has described the prevalence of asthma, allergic rhino-
conjunctivitis and atopic eczema in over 155 centres from 56 countries and has 
'mapped' the prevalence of these conditions in two age groups (6 17 and 13/14 
years of age) (Warner, 1999). 
For the 13 and 14 year age group, the range in self reported 12 month prevalence 
of symptoms of wheeze was very large, ranging from 2.1 - 4.4°/o in Albania, China, 
Greece, Georgia, Indonesia, Romania and Russia to 29.1 - 32.2°/o in Australia, 
New Zealand, Republic of Ireland and the UK. There were a number of interesting 
regional trends, including a strong Northwest (high) to Southeast (low} gradient 
within Europe. For the 6 and 7 year age group, parental reports showed a 12-
month prevalence of wheeze, ranging from 4.1 - 32.1 °/o with the lowest rates in 
India, Indonesia, Iran and Malaysia and the highest rates in Australia, Brazil, Costa 
Rica, New Zealand and Panama. The international patterns of wheeze and 
asthma symptom prevalence that were observed could not be explained by our 
current understanding of the causation of asthma. (ISAAC International Data 
Centre, 2000}. 
Norzila (2000), examined the intra-observer reliability of the Malay language 
versions of two international respiratory questionnaires, i.e. the International Study 
of Asthma and Allergy in Children (ISAAC} and the American Thoracic Society 
(ATS) questionnaires, and using the more reliable of these questionnaires, to 
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estimate the prevalence of asthma and allergy related symptoms in an ethnically 
homogeneous inner city community in Kuala Lumpur. 
The Malay translations of both ISAAC and ATS questionnaires were administered 
to 787 school children aged 7 to 12 years old of Malay ethnic in an inner city of 
Kuala Lumpur which were answered by their parents. 
She found that the translated ISAAC questionnaire was more reliable than the 
translated ATS questionnaire. Asthma and related symptoms were common 
among Malay school children in the inner city of Kuala Lumpur. 
From her study, according to the ISAAC questionnaire the prevalence of ever 
wheezes, wheezes in the last 12 months, ever asthma, and wheezes with exercise 
in the last 12 months was 12.5°/o, 6.6°/o, 1 0.3°/o and 5.9°/o respectively. The 
prevalence of ever sneeze or runny nose, sneeze or runny nose in the last 12 
months, watery eyes in the last 12 months and eczema was 15.2o/o, 11.1 °/o, 4.4°/0 
and 8.5°/o respectively. 
In our local set up in 1995, a study by Quah (1997) using written ISAAC 
questionnaire administered to 7055 school children in 1995 reported a prevalence 
of 'ever wheeze', 'wheeze in the last 12 months' and 'diagnosed asthma' of 9.4°/0 , 
6.0o/o and 9.4°/o respectively. He studied two age groups (5 to 7 year old and 12 to 
14 year old) and found that the older age group had more severe asthma 
symptoms (by frequency of recent wheeze and their sleep disturbance). He also 
found a prevalence of 'rhinitis ever' about 27°/o and 'eczema ever' of 12°/o. 
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Reported wheeze has frequently been used as a surrogate marker for asthma and 
is considered central to diagnosing asthma and measuring asthma prevalence. 
ISAAC questionnaire used wheeze as one of the indicator for asthma. Assuming 
that wheeze could be considered a homogenous symptom, there are no exact 
equivalents of wheeze in some languages. Similarly, there is no exact word in the 
Malay language those equivalents to wheeze. 
It is not known whether the translation of wheeze and other respiratory symptoms 
to the Malay language is the same with parents' interpretation in order for them to 
answer correctly. 
Recent quantitative research done by Cane et al. (2000), has found that parents' 
concepts of wheeze differ from those used in epidemiological surveys, and that 
parents use the term "wheeze" to describe a range of respiratory noises, only 
some of which conform to a clinical definition of wheeze. 
Cane and McKenzie (2001) noted parents locate sounds better than describing 
them. At least 30°/o of all parents use other words for wheeze and 30o/o labelled 
other sounds as 'wheeze'. 
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Young et al. (2002) also found that parents in their study offered descriptions of 
wheeze, which included terms that do not usually feature in classic clinical 
descriptions of wheeze. As in many survey instruments, including the ISAAC 
questionnaire, whistling was used as a descriptor for wheeze, but their findings 
suggest it might be misleading or confusing to use this description without some 
qualification. 
Elphick et al. (2001) did a study to investigate terminologies used by parents to 
describe their children's breathing sounds. They found that wheeze was the most 
commonly chosen word on initial questioning (59%)). Only 36°/o were still using this 
term at the end of the interview, representing a decrease of one third, whereas the 
use of the word "ruttles" doubled. They concluded that their results reflect the 
degree of inaccuracy involved in the use of the term wheeze in clinical practice, 
which may be leading to over diagnosis of asthma. 
The aim of this study is to investigate the words used by parents to describe their 
children's respiratory symptoms. Words used by parents to describe their child's 
respiratory symptoms will guide us in knowing whether their interpretation of these 
symptom were as expected in survey questions and enable us to use these words 
in studies of prevalence of asthma in our population. 
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To do this it is essential to understand how parents identify, classify and 
experience their children's respiratory symptoms for them to interpret key 
questions in survey instrument. 
This study also tries to describe the symptoms used by parents in other atopic 
diseases, such as allergic rhinitis and eczema. 
Asthma and allergic rhinitis are linked in several ways. The shared immunology 
pathogenesis is nasal bronchial reflex and allergen sensitisation. Epidemiological 
studies have also shown a link between asthma and allergy. There is 
interrelatedness of the upper and lower airway function, the link operating 
directionally from the sinuses to the lungs. In addition, there is a co-occurrence of 
asthma and allergic rhinitis in the population. 
Furthermore, both conditions respond to similar treatments, including anti-
histamine-containing therapies that may ameliorate allergic rhinitis and also 
potentially help alleviate asthma symptoms. (DuBuske, 1999) 
For asthma and atopic eczema, the immunobiology of these disorders have shown 
a common pathophysiological basis of an exaggerated and inappropriate lgE 
mediated inflammation in response to allergen exposure, this is referred as allergy. 
(Sheikh- ,2002) 
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The ISAAC study (ISAAC International Data Center, 2000) showed the prevalence 
of rhinitis with itchy-watery eyes ("allergic rhinoconjunctivitis") in the past year 
varied across centres from 0.8°/o - 14.9°/o in the 6/7 year olds and from 1.4o/o -
39.7% in the 13/14 year olds. Within each age group, the global pattern was 
broadly consistent across each of the symptom categories. In centres of higher 
prevalence there was great variability in the proportion of rhinoconjunctivitis 
labelled as hay fever. The lowest prevalence of rhinoconjunctivitis was found in 
parts of Eastern Europe, South and Central Asia. High prevalence was reported 
from centres in several regions. 
variations in the prevalence 
rh in aeon ju ncti viti s. 
The results suggest substantial worldwide 
and labelling of symptoms of allergic 
The ISAAC study also showed that the prevalence range for symptoms of atopic 
eczema was similar in both age groups, from less than 2°/o to over 16°/o and less 
than 1°/0 to over 17°/o in the 6/7 and 13/14 year age groups respectively. A higher 
prevalence of atopic eczema symptoms was reported in Australasia, Northern 
Europe and some centres in Africa and lower symptom prevalence was reported in 
Eastern and Central Europe and Asia. Similar patterns were seen for symptoms of 
severe atopic eczema. The results also suggest substantial worldwide variation in 
the prevalence and labelling of symptoms of atopic eczema. 
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This study aims to determine words used by the parents to describe these atopic 
diseases in the Malay language. As with asthma, it is essential to understand how 
parents identify and classify these symptoms for them to interpret the questions in 
survey instrument. 
As asthma is the most common chronic illness of childhood, a better 
understanding of parents' attitude towards inhaled asthma medication would be 
helpful in improving asthma educational programmes and therefore ensure a better 
patient compliance with therapy. Therefore, their perceptions towards asthma 
medication should be evaluated in order to ensure patient compliance and the 
effectiveness of the therapy. 
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2. LITERATURE REVIEW 
2.1 DEFINITIONS AND DIAGNOSIS OF ASTHMA 
Estimates of the prevalence of asthma in childhood are higher in developed 
countries than in developing areas of the world. The lack of an agreed definition for 
asthma leads to inconsistent diagnostic practices, which may partially explain 
these differences. Thus data are not easily compared and provide little information 
that can be used in health planning or in defining the causative agent. (Ferris 1978; 
Gregg 1986) 
A physician faces many challenges in making a definitive diagnosis of asthma in 
young children. Although there are clinical and historical features consistent with 
asthma, identical features are present in many other diseases. Furthermore there 
is no specific test for asthma. Other disease must always be ruled out before a 
definitive diagnosis of asthma is made. 
The working definition of asthma set forth in the Guidelines for the Diagnosis and 
Management of asthma prepared for the National Heart, Lung, and Blood 
Institute's National Asthma Education and Prevention Programme (NAEPP) 
indicates that asthma is a chronic inflammatory disorder of the airways 
characterized by recurrent episodes of wheezing, breathlessness, chest tightness, 
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and coughing. Furthermore these episodes are usually associated with 
widespread, but variable airflow obstruction. 
Although this definition of asthma is technically correct, it is not helpful in making 
diagnosis in young children. Chronic inflammation can be present in other lung 
diseases and can cause the same pattern of recurrent chest symptoms. Because 
there is no specific test for asthma, other diseases must be ruled out before a 
diagnosis of asthma can be made. (Strunk, 2002). 
Makino (1996) stated that asthma is characterized clinically with repeated 
episodes of wheezes and dyspnoea, associated with at least a partially reversible 
airway narrowing, physiologically increased airway responsiveness, a 
pathologically inflammation of the airway with the infiltration of eosinophils, T cells 
and mast cells, immunologically in around two thirds of patients, increased 
production of lg E antibodies to environmental allergens. 
Kemp and Kemp (2001) propose asthma as a chronic inflammatory disorder that 
produces airway hyper-responsiveness, airflow limitation and. persistent respiratory 
symptoms, such as wheezing, coughing, chest tightness and shortness of breath. 
Acute bronchoconstriction, airway oedema, mucus plug formation and airway 
remodelling produce airflow limitation. 
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A number of studies have suggested that asthma is under diagnosed, particularly 
in children. (Kaur et al, 1998). To make a diagnosis of asthma, a history of 
recurrent respiratory symptoms must be established, alternative diagnosis must be 
excluded, and reversible airflow obstruction must be demonstrated. Problems 
associated with making a diagnosis include the frequent remission and 
exacerbation of symptoms, the inability to perform spirometry in young children, 
the lack of availability of spirometric equipment in most paediatric offices, and 
frequent symptoms of cough in the presence of viral infections. 
Hall et al (2001) did a survey to aid providers in the diagnosis of paediatric asthma. 
The survey is part of a comprehensive asthma management programme called 
Easy Breathing, which was implemented in Hartford, Connecticut. The aim was to 
determine the sensitivity, specificity, and predictive value of a simple, self-
administered questionnaire for the diagnosis of asthma in children. 
They designed this study by developing the questionnaire to assist primary care 
providers in making a diagnosis of asthma in children and were administered in 4 
different primary care and subspecialty clinics, validated, and then used as part of 
an asthma management programme called Easy Breathing. Asthma diagnoses 
were made according to recommended National Asthma Expert Panel Guidelines. 
They found that 4 questions on survey were shown to be sensitive and specific for 
asthma. 
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The 4 questions are: 
1. wheezing 
2. nocturnal cough 
3. exercise induced respiratory symptoms 
4. persistent cough with cold. 
The sensitivity was greater for all levels (mild, moderate, severe) of persistent 
asthma than for intermittent asthma. A positive response to any one of the 4 
questions was over 94°/o sensitive for asthma; a negative response to all 4 
questions was 55°/o specific for ruling out asthma. 
They concluded that patient responses to 4 specific respiratory symptoms 
questions could assist primary care providers in diagnosing asthma in children. 
Primary care providers serving paediatric populations at high risk for asthma 
should consider asking patients or their parents these 4 questions regarding 
asthma symptoms on a regular basis. 
Most of the previous attempts to develop diagnostic instruments for asthma have 
been for adults. The ISAAC questionnaire developed and validated specifically for 
use in paediatric epidemiological studies is not useful for practitioners' practice. 
These previous attempts to validate asthma surveys used reactivity to bronchial 
challenge testing with histamine or exercise as the diagnosis gold standard. 
However, bronchial challenge testing is even less useful in paediatric practice 
because it cannot be used in children less than 7 years old and it is not practical to 
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use in large populations of children. For these reasons, in order to achieve greater 
specificity and consistency across age ranges, Hall et al (2001) used clinical 
diagnosis of asthma as their standard. This approach is consistent with The 
National heart, Lung, and Blood Institute National Asthma Expert Panel Asthma 
Guidelines in which episodic symptoms of airflow obstruction with exclusion of 
other diagnoses are the basis for a diagnosis of asthma and they reported higher 
specificity and similar sensitivity than reported for the other in.struments. 
(Hall et al, 2001) 
From the reasons that have been stated above, we have chosen all children with 
doctor diagnosed asthma (clinical diagnosis of asthma) for ease of recruitment of 
our study. Furthermore, we do not have any expertise or facility for the bronchial 
challenge test. 
13 
2.2 PREVALENCE OF ASTHMA 
The prevalence of paediatric asthma has risen sharply over the past 30 years, as 
has its impact on childhood and associated costs (Wood, 2002). 
2.2.1 Prevalence of asthma in Western countries 
Asthma prevalence is generally higher in Western countries than in developing 
countries. This pattern is illustrated by the European Community Respiratory 
Health Survey (ECRHS) findings in which the rates for "wheezing in the last year" 
are considered. The median prevalence for ECRHS study was 20.7°/o, with a range 
in the Western countries of 8.5°/o (Pavia) to 32.0°/o (Dublin). However, the 
prevalence was 4.2°/o in Algiers and 4.1 o/o in Bombay. Similar observations were 
made in the preliminary report of the ISAAC findings from the Southeast Asian 
region. (Beasley, 2000) 
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2.2.2 Asthma prevalence is increasing in developing countries as they become 
more westernised or become urbanized. 
Asthma prevalence is increasing in developing countries as they become more 
westernised. For example, Hsieh and Tsai examined the prevalence of allergic 
disorders in school children of 7 and 15 years of age in Taipei, Taiwan, and found 
that prevalence of childhood asthma increased from 1.3°/o in 197 4 to 5.1 o/o in 1985 
and 5.8°/o in 1991. (Beasley, 2000) 
Similar findings have been observed when communities move from a rural to an 
urban environment. The magnitude of the increase in asthma prevalence that may 
occur with urbanization would be considerable. For example,.in a study from the 
1970s the prevalence of asthma among Xhosa children living in a Cape Town 
township was more than 20 times greater than those from a rural area in the 
Transkei. Similar findings have been observed in a more recent study from 
Zimbabwe, in which exercise induced asthma was used as a more objective 
marker of reversible airflow obstruction. In this study, 25 to 50 fold differences 
between rural and urban populations were observed, findings that could not be 
accounted for by genetic factors. (Beasley, 2000). 
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2.2.3 Changing prevalence of asthma 
Annual Health Interview Surveys have disclosed increases in self-reported 
prevalence of asthma in the United States from 30.7 per 1000 in 1980 to 53.8 in 
1993-1994. The greatest proportionate increase has occurred in children less than 
5 years of age with a 160o/o increase from 22.2 per 1000 in 1980 to 57.8 in 1993-
1994. For children of 5 to 14 years of age, the prevalence increased from 42.8 per 
1000 in 1980 to 74.4 in 1993-1994, an increase of 74°/o. (Sly, 1999) 
Other national data from the National Centre Health Statistics indicate increases in 
cumulative prevalence of asthma at 6 to 11 years of age from 1976 to 1980 as 
compared with 1971 to 197 4. The second National Health and Nutrition 
Examination Survey of 1976 to 1980 also indicated a higher prevalence of 
physician-diagnosed current asthma and/or wheezing at 3 to 17 years of age in 
more boys than girls (7.8°/o versus 5.5°/o, P <0.01 ). Prevalence also was greater 
among children living in urban areas compared with rural areas. (Sly, 1999). 
Akinbami & Schoendorf (2002) published a study on trends in childhood asthma. 
The objectives of their study was to produce a comprehensive description of trends 
in childhood asthma prevalence, health care utilization, and mortality to asses the 
disease burden among United States children by using the national data. 
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Five data sources from National Center for Health Statistics were used to describe 
trends in asthma for children aged 0 to 17 years from 1980 to the most recent year 
for which data were available. These included the National Health Interview Survey 
(NHIS), the National ambulatory Medical Care Survey, the National Hospital 
Discharge Survey, and the Mortality Component of the National Vi tal Statistics 
System. 
The results were that asthma prevalence increased by an average of 4.3% per 
year from 1980 to 1996, from 3.6% to 6.2%. The peak prevalence was 7.5% in 
1995. In 1997, asthma attack prevalence was 5.4%, but changes in the NHIS 
design in 1997 precluded comparison to previous estimates. Asthma attack 
prevalence remains at level from 1997 to 2000. After the decrease between 1980 
a nd 1989, the asthma offi ce visit rates increased by an average of 3.8% per year 
from 1989 to 1999. Although childhood asthma death is rare, the asthma death 
rate increased by 3.4% per year from 1980 to 1998. Children aged 0 to 4 years 
have the largest increase in prevalence and a greater health care use, but 
adolescents have the highest mortality. The recent data suggest that the burden 
from childhood asthma may have recently reached a plateau after of several years 
of increasing, although additional years of data collection are necessary to confirm 
the change in trend. 
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In view that Malaysia is a developing country, the probability of the changing 
prevalence of asthma also occurred in our country. However, additional and 
continuous studies are necessary to confirm the changes in trend. 
As mentioned before, most of the studies on prevalence of asthma are based on 
the data from questionnaires about asthmatic symptoms. A better understanding 
on how parents interpret key questions in the survey instrument is important to 
ensure that it represent the true data. We were therefore prompted to evaluate the 
words used by parents to interpret common respiratory symptoms of asthma. 
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2.3 ADHERENCE TO ASTHMA THERAPY 
Asthma is a serious chronic inflammatory disease affecting people worldwide. 
If managed appropriately, hospitalisation is rare, yet over 40 percent of costs are 
related to emergency services and hospitalisations that result from the failure to 
effectively use preventive treatment. Studies found that patient who follow the 
recommended management programme tend to do well clinically. However, 
objective measures show that fewer than 50o/o of patients with asthma take their 
inhaled medication as prescribed. (Stoloff, 2000). 
Growing evidence reveals that many patients with severe asthma do not adhere to 
their treatment. Across various chronic diseases, including asthma, adherence 
improves as disease severity increases from mild to moderate but appears to 
reverse with severe illness. (Stoloff, 2000) 
Pharmacologic therapy is used to prevent and control asthma and reverse airflow 
obstruction. The major classes of asthma medications are beta-agonist, methyl 
xanthines, anticholinergic, leukotriene modifiers, non-steroidal anti-inflammatory 
drugs, and corticosteroids. The majority of these medications are inhaled, and their 
effectiveness in clinical practice can be affected by many factors. 
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The widespread introduction of aerosol therapy in the 1960s, in the form of a 
metered dose inhaler, was an important milestone in asthma management. 
Compared to the oral route of administration, inhaled therapy delivers higher 
concentrations of the drug directly to the airways with minimal side-effects. 
Consequently, much effort has been put into improving inhaled drug delivery by 
development of devices such as spacers and self-actuation devices. (Lim et al, 
1996) 
Despite the obvious advantages of inhalation therapy, patient acceptance to the 
use of inhaled medication is a crucial factor in ensuring patient compliance and 
therefore the effectiveness of therapy. 
Cochrane et al (2000) examined three factors influencing the effectiveness of 
asthma treatment with inhaled corticosteroids in practice: patient compliance, 
inhalation technique, and lung aerosol deposition. They found that only a small 
percentage of the prescribed dose of an inhaled corticosteroid is likely to reach the 
target organ, the lungs, because of non-compliance with the prescribed dose, 
difficulty in the correct use of the inhaler, and the ability of a properly used inhaler 
to deliver the drug to the lungs. 
Baumann et al (2002) did a study to examine the relationship of baseline 
nonadherence to subsequent asthma morbidity among inner -city children of the 
20 
United States. They found that the children whose caregivers were poor on either 
adherence measures had worse morbidity than those with good adherence, eg 
rate of hospitalisation was twice as high, they missed more than twice as much 
school, had poorer overall functioning, experienced more days of wheezing and 
had more restricted days of activity. 
Bender (2002) found that inadequate patient adherence to prescribed treatment 
regimens is a major cause of poor clinical outcomes in the treatment of asthma. 
Among children with asthma, adherence rates are often below 50°/o. Multiple 
treatments, clinician and patient related barrier prevent the achievement of 
satisfactory levels of adherence. Treatment related barriers include prolonged and 
complex regimens, adverse effects, costs, and delayed onset of action. Clinician 
related barriers include difficulty in scheduling, treatment by one different care-
giver after another, perceived clinician disinterest and time constraints. Patient 
related barriers include mild or severe asthma, poor understanding of the need for 
treatment, insufficient confidence in the clinician or medication, the presence of 
psychological problems and low motivation to change behaviour. 
Although, all of these factors must be addressed to maximise adherence, patient 
motivation may be the most critical. This task falls primarily to clinicians 
(physicians, nurses, staff), and it requires thorough patient and care-giver 
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education, more frequent patient contact, and the development of a patient 
clinician partnership dedicated to the effective treatment of asthma. 
In view of problems in compliance to treatment, we were therefore prompted to 
evaluate parents' perceptions and attitudes towards the use of inhaled medication. 
A better understanding of the parents' attitude towards inhaled asthma 
medications would be helpful in improving asthma educational programmes and 
therefore ensure better patient compliance with therapy. 
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OBJECTIVES: 
The aims of this study are 
1. To investigate parents' interpretations of common symptoms of asthma and 
atopic diseases. 
2. To describe parents' perception towards the use of inhaled medication for 
asthma therapy. 
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METHODOLOGY 
1. Design of study 
This study was conducted by interviewing the parents of children with asthma who 
attended the paediatric asthma clinic Hospital Universiti Sains Malaysia (HUSM) or 
Hospital Kota Bharu (HKB) and also whose children were admitted to the 
paediatric general ward HUSM for asthma from March 2001 to September 2002. 
This is a hospital-based study and the characteristics of the sample may not be the 
same as the general population. During this period a convenient sample of 165 
children with asthma were selected for the study. Therefore not all children with 
asthma seen in these hospitals during the study period were included. 
Another 170 children without asthma were selected as controls. The controls were 
children without asthma who attended the paediatric clinic HUSM for other medical 
problems or who were admitted to the paediatric ward HUSM for non-asthmatic 
diseases. 
Patients who were diagnosed and treated for asthma in the ward or clinic, if their 
parents gave verbal consent for the interview, were included in the study. 
Permission to do this study was officially obtained from the Heads of the Paediatric 
Department in Hospital Kota Bharu and in Hospital USM. 
24 
